Related Experiment Video

Updated: Aug 10, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
10:21

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix

Published on: June 14, 2016

[Genetic changes and clinical management in familial hypertrophic cardiomyopathy]

D Domal-Kwiatkowska, S Smolik, U Mazurek

    Wiadomosci Lekarskie (Warsaw, Poland : 1960)
    |May 12, 2000
    PubMed

    Insights

    Hypertrophic cardiomyopathy (HCM) is a genetic heart disease affecting sarcomere proteins. Genetic mutations influence disease severity and sudden cardiac death (SCD) risk, aiding diagnosis and prognosis.

    Area of Science:

    • Cardiovascular Genetics
    • Molecular Cardiology
    • Genetic Basis of Heart Disease

    Background:

    • Hypertrophic cardiomyopathy (HCM) is a genetically heterogeneous heart muscle disease.
    • It involves mutations in genes encoding sarcomere proteins, crucial for cardiac contraction.
    • Nine chromosomal loci and over 107 mutations have been identified, primarily in the beta-myosin heavy chain (beta-MHC) gene.

    Discussion:

    • Specific mutations, like those in beta-MHC, correlate with varying disease severity and sudden cardiac death (SCD) risk.
    • Mutations in myosin binding protein C are linked to milder, delayed hypertrophy with a benign prognosis.
    • Cardiac troponin T mutations can cause mild hypertrophy but carry a high risk of SCD.

    Key Insights:

    • HCM is classified as a cardiac sarcomere disease due to its genetic underpinnings.
    • The location and type of genetic mutation significantly impact clinical presentation, prognosis, and risk of SCD.
    • Genetic analysis is crucial for understanding disease heterogeneity.

    Outlook:

    • Understanding HCM-associated genes is vital for improving clinical management.
    • Genetic insights will enhance diagnostic accuracy and prognostic predictions for patients and families.
    • Future research may focus on genotype-phenotype correlations for personalized treatment strategies.

    More Related Videos

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level06:02

    An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

    Published on: November 2, 2020

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

    Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

    Published on: August 8, 2022

    Related Concept Videos

    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Cardiomyopathy VI: Nursing Management01:29

    Cardiomyopathy VI: Nursing Management

    Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
    Cellular Adaptation II: Hypertrophy01:26

    Cellular Adaptation II: Hypertrophy

    Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...